A study on the cognitive intervention effects of a mindfulness-based recovery enhancement mode intervention program for stroke patients: A non-randomized Controlled Trial

Research on the Cognitive Function Effects of an Intervention Program Based on Mindfulness-Oriented Recovery Enhancement for Stroke Patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300078159

Enrollment

Unknown

Registered

2023-11-30

Start date

2023-11-30

Completion date

Unknown

Last updated

2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

MORE group:Modified version of Mindfulness-Oriented Recovery Enhancement therapy + Conventional rehabilitation treatment

Control group:Conventional rehabilitation treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Stroke patients diagnosed by imaging (head CT or MRI); age = 18 years; ? In the recovery period (duration of illness > 14 days); ? Stable vital signs and clear consciousness, able to actively cooperate in training; ? Chief complaint of memory or cognitive decline or Clinical Dementia Rating (CDR) score =0.5; ?13<MoCA<27

Exclusion criteria

Exclusion criteria: ?Individuals with consciousness disorders; ?Those who are unable to communicate or perform autonomous activities due to swallowing disorders, tracheostomy, endotracheal intubation, or other conditions; ?Patients who are unable to cooperate with cognitive function tests or other examinations (such as deafness, blindness, aphasia, etc.); ?Those who had a diagnosed cognitive impairment or dementia with medical record documentation before the onset of stroke this time; ?Neurological or other medical conditions that affect the central nervous system function; ?Subjects who are unwilling or unable to continue participating in the trial; ?Those whose condition worsens or develop psychological problems that make them unsuitable to continue participating in the trial; ?Currently taking medication that significantly alters cognitive ability; ?Starting new neuro/psychiatric medication treatment one week before the first data collection; ?Currently using specified cognitive interventions or electromagnetic stimulation therapy.

Design outcomes

Primary

Measure	Time frame
cognition;executive function;memory;attention;	—

Secondary

Measure	Time frame
physical function;Activities of Daily Living;depression;Mindful Attention Awareness ;resilience;Loneliness;	—

Countries

China

Contacts

Public ContactJuan Li

Huashan Hospital Affiliated to Fudan University

lijuanjr@126.com+86 137 8899 6816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026